Successful Treatment of Anti-MDA5 Antibody-Positive Dermatomyositis-Associated Rapidly Progressive-Interstitial Lung Disease by Plasma Exchange: Two Case Reports

Background: Patients with anti-melanoma differentiation-associated gene 5 (MDA5) antibody-positive dermatomyositis (DM) are frequently accompanied by rapidly progressive-interstitial lung disease (RP-ILD). They are often refractory to intensive immunosuppressive therapy and have poor prognosis. Case...

Full description

Bibliographic Details
Main Authors: Rina Takahashi, Tadashi Yoshida, Kohkichi Morimoto, Yasushi Kondo, Jun Kikuchi, Shuntaro Saito, Sho Ishigaki, Yuko Kaneko, Tsutomu Takeuchi, Hiroshi Itoh, Mototsugu Oya
Format: Article
Language:English
Published: SAGE Publishing 2021-07-01
Series:Clinical Medicine Insights: Case Reports
Online Access:https://doi.org/10.1177/11795476211036322
id doaj-86267068bdef429091a3f0db5b631dc2
record_format Article
spelling doaj-86267068bdef429091a3f0db5b631dc22021-07-28T02:33:29ZengSAGE PublishingClinical Medicine Insights: Case Reports1179-54762021-07-011410.1177/11795476211036322Successful Treatment of Anti-MDA5 Antibody-Positive Dermatomyositis-Associated Rapidly Progressive-Interstitial Lung Disease by Plasma Exchange: Two Case ReportsRina Takahashi0Tadashi Yoshida1Kohkichi Morimoto2Yasushi Kondo3Jun Kikuchi4Shuntaro Saito5Sho Ishigaki6Yuko Kaneko7Tsutomu Takeuchi8Hiroshi Itoh9Mototsugu Oya10Division of Endocrinology, Metabolism and Nephrology, Department of Internal Medicine, Keio University School of Medicine, Shinjuku-ku, Tokyo, JapanApheresis and Dialysis Center, Keio University School of Medicine, Shinjuku-ku, Tokyo, JapanApheresis and Dialysis Center, Keio University School of Medicine, Shinjuku-ku, Tokyo, JapanDivision of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Shinjuku-ku, Tokyo, JapanDivision of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Shinjuku-ku, Tokyo, JapanDivision of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Shinjuku-ku, Tokyo, JapanDivision of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Shinjuku-ku, Tokyo, JapanDivision of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Shinjuku-ku, Tokyo, JapanDivision of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Shinjuku-ku, Tokyo, JapanDivision of Endocrinology, Metabolism and Nephrology, Department of Internal Medicine, Keio University School of Medicine, Shinjuku-ku, Tokyo, JapanDepartment of Urology, Keio University School of Medicine, Shinjuku-ku, Tokyo, JapanBackground: Patients with anti-melanoma differentiation-associated gene 5 (MDA5) antibody-positive dermatomyositis (DM) are frequently accompanied by rapidly progressive-interstitial lung disease (RP-ILD). They are often refractory to intensive immunosuppressive therapy and have poor prognosis. Case presentation: A 73-year-old woman presented with fever, cold symptoms, and skin eruption for a month. She also exhibited muscle weakness on upper extremities slightly. The titer of anti-MDA5 antibody was extremely high, and computed tomography showed ground glass opacity and reticular shadows in the lungs. She was diagnosed as anti-MDA5 antibody-positive classical DM-associated RP-ILD and treated with intensive immunosuppressive therapy. However, the titer of anti-MDA5 antibody did not decrease satisfactorily, and plasma exchange was alternatively initiated. The titer decreased remarkably, and she obtained disease remission. Similarly, a 63-year-old woman presented with stiffness of the neck and hands, fever and cough. She was also diagnosed as anti-MDA5 antibody-positive classical DM-associated RP-ILD, because she had skin eruptions, slight muscle weakness, an elevation in anti-MDA5 antibody, and RP-ILD. She was unresponsive to intensive immunosuppressive therapy, but plasma exchange successfully improved the titer of anti-MDA5 antibody, the symptoms, and the findings of computed tomography. Conclusions: Although anti-MDA5 antibody-positive DM-associated RP-ILD has a high mortality rate, this report suggests the usefulness of plasma exchange to improve the prognosis.https://doi.org/10.1177/11795476211036322
collection DOAJ
language English
format Article
sources DOAJ
author Rina Takahashi
Tadashi Yoshida
Kohkichi Morimoto
Yasushi Kondo
Jun Kikuchi
Shuntaro Saito
Sho Ishigaki
Yuko Kaneko
Tsutomu Takeuchi
Hiroshi Itoh
Mototsugu Oya
spellingShingle Rina Takahashi
Tadashi Yoshida
Kohkichi Morimoto
Yasushi Kondo
Jun Kikuchi
Shuntaro Saito
Sho Ishigaki
Yuko Kaneko
Tsutomu Takeuchi
Hiroshi Itoh
Mototsugu Oya
Successful Treatment of Anti-MDA5 Antibody-Positive Dermatomyositis-Associated Rapidly Progressive-Interstitial Lung Disease by Plasma Exchange: Two Case Reports
Clinical Medicine Insights: Case Reports
author_facet Rina Takahashi
Tadashi Yoshida
Kohkichi Morimoto
Yasushi Kondo
Jun Kikuchi
Shuntaro Saito
Sho Ishigaki
Yuko Kaneko
Tsutomu Takeuchi
Hiroshi Itoh
Mototsugu Oya
author_sort Rina Takahashi
title Successful Treatment of Anti-MDA5 Antibody-Positive Dermatomyositis-Associated Rapidly Progressive-Interstitial Lung Disease by Plasma Exchange: Two Case Reports
title_short Successful Treatment of Anti-MDA5 Antibody-Positive Dermatomyositis-Associated Rapidly Progressive-Interstitial Lung Disease by Plasma Exchange: Two Case Reports
title_full Successful Treatment of Anti-MDA5 Antibody-Positive Dermatomyositis-Associated Rapidly Progressive-Interstitial Lung Disease by Plasma Exchange: Two Case Reports
title_fullStr Successful Treatment of Anti-MDA5 Antibody-Positive Dermatomyositis-Associated Rapidly Progressive-Interstitial Lung Disease by Plasma Exchange: Two Case Reports
title_full_unstemmed Successful Treatment of Anti-MDA5 Antibody-Positive Dermatomyositis-Associated Rapidly Progressive-Interstitial Lung Disease by Plasma Exchange: Two Case Reports
title_sort successful treatment of anti-mda5 antibody-positive dermatomyositis-associated rapidly progressive-interstitial lung disease by plasma exchange: two case reports
publisher SAGE Publishing
series Clinical Medicine Insights: Case Reports
issn 1179-5476
publishDate 2021-07-01
description Background: Patients with anti-melanoma differentiation-associated gene 5 (MDA5) antibody-positive dermatomyositis (DM) are frequently accompanied by rapidly progressive-interstitial lung disease (RP-ILD). They are often refractory to intensive immunosuppressive therapy and have poor prognosis. Case presentation: A 73-year-old woman presented with fever, cold symptoms, and skin eruption for a month. She also exhibited muscle weakness on upper extremities slightly. The titer of anti-MDA5 antibody was extremely high, and computed tomography showed ground glass opacity and reticular shadows in the lungs. She was diagnosed as anti-MDA5 antibody-positive classical DM-associated RP-ILD and treated with intensive immunosuppressive therapy. However, the titer of anti-MDA5 antibody did not decrease satisfactorily, and plasma exchange was alternatively initiated. The titer decreased remarkably, and she obtained disease remission. Similarly, a 63-year-old woman presented with stiffness of the neck and hands, fever and cough. She was also diagnosed as anti-MDA5 antibody-positive classical DM-associated RP-ILD, because she had skin eruptions, slight muscle weakness, an elevation in anti-MDA5 antibody, and RP-ILD. She was unresponsive to intensive immunosuppressive therapy, but plasma exchange successfully improved the titer of anti-MDA5 antibody, the symptoms, and the findings of computed tomography. Conclusions: Although anti-MDA5 antibody-positive DM-associated RP-ILD has a high mortality rate, this report suggests the usefulness of plasma exchange to improve the prognosis.
url https://doi.org/10.1177/11795476211036322
work_keys_str_mv AT rinatakahashi successfultreatmentofantimda5antibodypositivedermatomyositisassociatedrapidlyprogressiveinterstitiallungdiseasebyplasmaexchangetwocasereports
AT tadashiyoshida successfultreatmentofantimda5antibodypositivedermatomyositisassociatedrapidlyprogressiveinterstitiallungdiseasebyplasmaexchangetwocasereports
AT kohkichimorimoto successfultreatmentofantimda5antibodypositivedermatomyositisassociatedrapidlyprogressiveinterstitiallungdiseasebyplasmaexchangetwocasereports
AT yasushikondo successfultreatmentofantimda5antibodypositivedermatomyositisassociatedrapidlyprogressiveinterstitiallungdiseasebyplasmaexchangetwocasereports
AT junkikuchi successfultreatmentofantimda5antibodypositivedermatomyositisassociatedrapidlyprogressiveinterstitiallungdiseasebyplasmaexchangetwocasereports
AT shuntarosaito successfultreatmentofantimda5antibodypositivedermatomyositisassociatedrapidlyprogressiveinterstitiallungdiseasebyplasmaexchangetwocasereports
AT shoishigaki successfultreatmentofantimda5antibodypositivedermatomyositisassociatedrapidlyprogressiveinterstitiallungdiseasebyplasmaexchangetwocasereports
AT yukokaneko successfultreatmentofantimda5antibodypositivedermatomyositisassociatedrapidlyprogressiveinterstitiallungdiseasebyplasmaexchangetwocasereports
AT tsutomutakeuchi successfultreatmentofantimda5antibodypositivedermatomyositisassociatedrapidlyprogressiveinterstitiallungdiseasebyplasmaexchangetwocasereports
AT hiroshiitoh successfultreatmentofantimda5antibodypositivedermatomyositisassociatedrapidlyprogressiveinterstitiallungdiseasebyplasmaexchangetwocasereports
AT mototsuguoya successfultreatmentofantimda5antibodypositivedermatomyositisassociatedrapidlyprogressiveinterstitiallungdiseasebyplasmaexchangetwocasereports
_version_ 1721279159690330112